You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國同輻(01763.HK):中核安科銳國產TOMO C項目獲批醫療器械註冊證及醫療器械生產許可證
阿思達克 09-28 12:06
中國同輻(01763.HK)公布,近日,中核安科銳成功獲批由國家藥品監督管理局(NMPA)發布關於中核安科銳國產高端螺旋斷層放射治療系統(Tomo C)項目的醫療器械註冊證及醫療器械生產許可證。該款產品將為臨床提供更為精準的放射治療,助力醫生為患者提供更加優異的腫瘤放射治療方案。 中核安科銳成立於2019年3月26日,是由集團的全資子公司中核高能(天津)裝備有限公司出資51%,安科銳亞洲有限公司出資49%組建而成的中外合資公司。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account